License Agreement
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China
Nuance Pharma
PR-M03-22-08Mar 21, 2022
Clinical Study
Pfizer Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine
Pfizer
PR-M05-18-NI-092May 24, 2018